Tavio Capital LLC - Q3 2017 holdings

$246 Million is the total value of Tavio Capital LLC's 10 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 60.0% .

 Value Shares↓ Weighting
ANTM BuyANTHEM INC$49,970,000
+10.7%
263,164
+9.7%
20.33%
-9.5%
BSX BuyBOSTON SCIENTIFIC CORP$49,425,000
+17.7%
1,694,366
+11.9%
20.11%
-3.8%
MOH BuyMOLINA HEALTHCARE INC$36,937,000
+414.9%
537,192
+418.0%
15.03%
+320.8%
CNC BuyCENTENE CORP DEL$28,715,000
+101.1%
296,731
+66.0%
11.68%
+64.4%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$22,709,000
-7.8%
204,697
+1.5%
9.24%
-24.6%
MCK NewMCKESSON CORP$21,563,000140,372
+100.0%
8.77%
SPY NewSPDR S&P 500 ETF TRtr unit$13,818,00055,000
+100.0%
5.62%
XBI NewSPDR SERIES TRUSTs&p biotech$10,027,000115,821
+100.0%
4.08%
RTRX  RETROPHIN INC$7,316,000
+28.4%
293,9230.0%2.98%
+4.9%
TDOC SellTELADOC INC$5,304,000
-27.2%
160,011
-23.8%
2.16%
-40.5%
HUM ExitHUMANA INC$0-73,098
-100.0%
-8.76%
AET ExitAETNA INC NEW$0-120,240
-100.0%
-9.09%
WBA ExitWALGREENS BOOTS ALLIANCE INC$0-241,213
-100.0%
-9.40%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-10-30
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC13Q2 202029.6%
CENTENE CORP DEL11Q2 202019.1%
ANTHEM INC10Q2 201922.5%
BOSTON SCIENTIFIC CORP9Q4 201920.9%
RETROPHIN INC9Q1 20193.4%
ZIMMER BIOMET HOLDINGS INC8Q2 202020.6%
HUMANA INC8Q4 201937.8%
UNIVERSAL HLTH SVCS INC8Q1 201914.7%
HCA HEALTHCARE INC8Q1 202012.3%
MCKESSON CORP7Q2 202023.1%

View Tavio Capital LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2020-10-01
13F-HR2020-08-13
13F-HR2020-05-14
13F-HR2020-02-13
13F-HR2019-11-13
13F-HR2019-08-13
13F-HR2019-05-14
13F-HR2019-02-14
13F-HR2018-11-13
13F-HR2018-08-13

View Tavio Capital LLC's complete filings history.

Compare quarters

Export Tavio Capital LLC's holdings